Celadon Pharmaceuticals Plc (CEL.L)

GBp 7.0

(7.69%)

Operating Expenses Summary of Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc's latest annual operating expenses in 2023 was 6 Million GBP , down -55.2% from previous year.
Celadon Pharmaceuticals Plc's latest quarterly operating expenses in 2024 Q1 was 1.14 Million GBP , up 125.1% from previous quarter.
Celadon Pharmaceuticals Plc reported a annual operating expenses of 12.85 Million GBP in annual operating expenses 2022, up 375.43% from previous year.
Celadon Pharmaceuticals Plc reported a annual operating expenses of 2.7 Million GBP in annual operating expenses 2021, up 275.08% from previous year.
Celadon Pharmaceuticals Plc reported a quarterly operating expenses of 1.14 Million GBP for 2024 Q2, down 0.0% from previous quarter.
Celadon Pharmaceuticals Plc reported a quarterly operating expenses of 3.32 Million GBP for 2023 Q2, up 60.56% from previous quarter.

Annual Operating Expenses Chart of Celadon Pharmaceuticals Plc (2023 - 2019)

Historical Annual Operating Expenses of Celadon Pharmaceuticals Plc (2023 - 2019)

Year	Operating Expenses	Operating Expenses Growth
2023	6 Million GBP	-55.2%
2022	12.85 Million GBP	375.43%
2021	2.7 Million GBP	275.08%
2020	720.64 Thousand GBP	1418.72%
2019	47.45 Thousand GBP	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.14 Million GBP	125.1%
2024 Q2	1.14 Million GBP	0.0%
2023 Q2	3.32 Million GBP	60.56%
2023 FY	5.75 Million GBP	-55.2%
2023 Q3	1.41 Million GBP	-57.31%
2023 Q1	2.06 Million GBP	-39.46%
2023 Q4	-4.54 Million GBP	-420.59%
2022 Q2	8.96 Million GBP	85.42%
2022 Q1	4.83 Million GBP	290.17%
2022 FY	12.85 Million GBP	375.43%
2022 Q4	3.41 Million GBP	57.09%
2022 Q3	2.17 Million GBP	-75.74%
2021 FY	2.7 Million GBP	275.08%
2021 Q2	830.42 Thousand GBP	554.04%
2021 Q4	1.23 Million GBP	384.71%
2021 Q1	126.96 Thousand GBP	-38.45%
2021 Q3	255.73 Thousand GBP	-69.2%
2020 Q4	206.3 Thousand GBP	132.72%
2020 Q2	154.02 Thousand GBP	57.32%
2020 Q1	97.9 Thousand GBP	0.0%
2020 FY	720.64 Thousand GBP	1418.72%
2020 Q3	88.64 Thousand GBP	-42.45%
2019 Q3	88.59 Thousand GBP	0.0%
2019 FY	47.45 Thousand GBP	0.0%
2019 Q1	77.95 Thousand GBP	0.0%

Peer Operating Expenses Comparison of Celadon Pharmaceuticals Plc

Name	Operating Expenses	Operating Expenses Difference